The medical bionics market is categorized into ear bionics (cochlear implants), vision bionics, exoskeletons, bionic limbs, brain bionics and cardiac bionics. High prevalence of occupation and age-related disabilities demands novel methods of patient rehabilitation to offer a better life for such patients. The market for exoskeletons is expected to emerge as the fastest growing segment, Transparency Market Research at a CAGR of over 15% from 2012 to 2018.
Geographically, North America leads the market for artificial vital organs and medical bionics. Aging of the baby boomer population and the corresponding rise in prevalence of acute cases of cardiovascular diseases, renal diseases and respiratory disorders, and the increase in prevalence of age-related disorders and occupation-related disabilities are the major drivers for the growth in demand for artificial organs in North America. However, improvement in healthcare expenditure and healthcare infrastructure and rising scope of medical tourism will increase the market share of Asia-Pacific in the future.
The key players in the artificial vital organs and medical bionics market include Abbott Diabetes Care, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc., Gambro AB, Medtronic, Inc., Nikkiso Co., Ltd., SynCardia Systems, Inc., Ossur Hf, WorldHeart Corporation, Ekso Bionics, Touch Bionics, Ottobock Healthcare Gmbh, Second Sight Medical Prod
Copyright©2012 Vocus, Inc.
All rights reserved